Prosecution Insights
Last updated: October 04, 2026
Application No. 17/629,606

HYDROPHILIZED INORGANIC POWDER AND COSMETIC INCLUDING HYDROPHILIZED INORGANIC POWDER

Non-Final OA §103§112
Filed
Jan 24, 2022
Priority
Jul 25, 2019 — nonprovisional of PCTJP2019029294
Examiner
HOERNER, PAUL ELLSWORTH
Art Unit
1611
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Miyoshi Kasei Inc.
OA Round
3 (Non-Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
41 granted / 82 resolved
-10.0% vs TC avg
Strong +62% interview lift
Without
With
+62.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
54 currently pending
Career history
119
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
50.2%
+10.2% vs TC avg
§102
11.0%
-29.0% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 82 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 22 April 2026 has been entered. Status of Claims The amendments and arguments filed 22 April 2026 are acknowledged and have been fully considered. Claims 1, 7, and 19 are currently pending. Claim 1 is amended; claims 2-6 and 8-18 are cancelled; no claims are withdrawn; claim 19 is new. Claims 1, 7, and 19 are examined on the merits herein. Objections/Rejections Withdrawn Rejections and/or objections not reiterated from previous Office Actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied, and constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 112(a) The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 7, and 19 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 recites a hydrophilized inorganic powder comprising an inorganic powder, a hydrophobic coat, and a hydrophilic coat, further reciting the hydrophilic coat comprises disodium stearoyl glutamate. However, the instant specification discloses disodium stearoyl glutamate only as the hydrophobic coating (Pars. [0014], [0028], [0036], [0071], and [0105] of the specification as filed; Original claims 6 and 9-12), with no disclosure of disodium stearoyl glutamate included in the hydrophilic coating. Therefore, the limitation of the hydrophilic coat comprising disodium stearoyl glutamate is new matter. Claims 7 and 19 are rejected due to their dependence on claim 1. Based on Applicant’s election of disodium stearoyl glutamate as the species of hydrophobic coating and in the interest of compact prosecution, claim 1 is interpreted as reciting “the composition of the hydrophobic coat comprises disodium stearoyl glutamate”. Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 19 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 19 contains the trademark/trade name Henschel. Where a trademark or trade name is used in a claim as a limitation to identify or describe a particular material or product, the claim does not comply with the requirements of 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph. See Ex parte Simpson, 218 USPQ 1020 (Bd. App. 1982). The claim scope is uncertain since the trademark or trade name cannot be used properly to identify any particular material or product. A trademark or trade name is used to identify a source of goods, and not the goods themselves. Thus, a trademark or trade name does not identify or describe the goods associated with the trademark or trade name. In the present case, the trademark/trade name is used to identify/describe industrial mixers and, accordingly, the identification/description is indefinite. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 7, and 19 are rejected under 35 U.S.C. 103 as being unpatentable over Lee et al. (US 2008/0188574) in view of Kubota et al. (US 2017/0007512) and Park et al. (KR 2018-0098773; of record). Claim 1 is drawn to a hydrophilized inorganic powder, comprising an inorganic powder as a base material, a hydrophobic coat that covers the surface of the inorganic powder, and a hydrophilic coat that covers the hydrophobic coat, wherein the hydrophilic coat has a composition being a nonionic surfactant having a hydrophilic moiety and a carbon chain moiety, the carbon chain moiety of the nonionic surfactant has a branched structure sufficient for imparting self-dispersibility to the inorganic powder having hydrophobicity, the inorganic powder comprises hydrophobic pigment grade titanium oxide, the composition of the hydrophobic coat comprises disodium stearoyl glutamate, and the nonionic surfactant comprises polyoxyethylene (10) isostearyl ether. Lee et al. teach cosmetic powders comprising a metal oxide powder base treated with a hydrophobic coat and a hydrophilic coat to allow for water dispersability (Abstract). Lee et al. further teach in Example 2 (Pg. 3) coating titanium dioxide powder with decyl triethyoxysilane to obtain a hydrophobic powder, followed by coating with the dispersant disodium tridecyl sulfosuccinate. As such, Lee et al. teach a hydrophilized inorganic powder, comprising an inorganic powder as a base material, a hydrophobic coat that covers the surface of the inorganic powder, and a hydrophilic coat that covers the hydrophobic coat, wherein the hydrophilic coat has a composition being a surfactant having a hydrophilic moiety and a carbon chain moiety, the carbon chain moiety of the nonionic surfactant has a branched structure sufficient for imparting self-dispersibility to the inorganic powder having hydrophobicity, and the inorganic powder comprises titanium dioxide. The powder of Lee et al. differs from the instantly claimed invention in the following ways: Lee et al. do not teach pigment grade titanium dioxide; the hydrophobic coat of Lee et al. does not comprise disodium stearoyl glutamate; and the hydrophilic coat of Lee et al. does not comprise polyoxyethylene (10) isostearyl ether. Yet, as to 1: Kubota et al. teach cosmetic compositions comprising a titanium dioxide powder with a hydrophobic coating (Claims 1 and 4). Kubota et al. further teach the titanium dioxide powder comprising pigment-grade titanium dioxide (Par. [0028]). Therefore, it would have been prima facie obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to have modified the powder of Lee et al. to comprise pigment-grade titanium dioxide as taught by Kubota et al. It would have been obvious to substitute one form of titanium dioxide powder suitable for use in cosmetics for another to obtain the predictable result of a coated titanium dioxide cosmetic powder, with a reasonable expectation of success. As to 2: Park et al. also teach inorganic powders having a hydrophobic coating for use in cosmetics (Pg. 5 sixth paragraph) wherein the inorganic powder can be a metal oxide (Pg. 5 seventh paragraph) such as titanium dioxide (Pg. 5 eighth paragraph), further teaching alkyl triethoxysilane (Pg. 5 tenth paragraph) and disodium stearoyl glutamate (Pg. 5 ninth paragraph) as suitable hydrophobic coatings for the metal oxide powder. Therefore, it would have been prima facie obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to have modified the powder of Lee et al. by substituting disodium stearoyl glutamate as taught by Park et al. in the place of decyl triethyoxysilane. It would have been obvious to substitute one hydrophobic coating taught to be suitable for metal oxide powders for use in cosmetics for another to obtain the predictable result of a metal oxide powder with a hydrophobic coating, with a reasonable expectation of success. And, as to 3: Lee et al. further teach in Example 5 (Pg. 3) using polyoxyethylene (10) cetyl/stearyl ether (i.e., the mixture of polyoxyethylene (10) stearyl ether and polyoxyethylene (10) cetyl ether) as the hydrophilic coating. Therefore, it would have been prima facie obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to have modified the composition of Lee et al. to include polyoxyethylene (10) stearyl ether. It would have been obvious to substitute one surfactant taught to be suitable as a dispersant for hydrophobic powders for another to obtain the predictable result of a hydrophilized powder, with a reasonable expectation of success. And as discussed in MPEP 2144.09(II), Compounds which are position isomers (compounds having the same radicals in physically different positions on the same nucleus) or homologs (compounds differing regularly by the successive addition of the same chemical group, e.g., by -CH2- groups) are generally of sufficiently close structural similarity that there is a presumed expectation that such compounds possess similar properties. In re Wilder, 563 F.2d 457, 195 USPQ 426 (CCPA 1977). In the instant case, polyoxyethylene (10) stearyl ether and polyoxyethylene (10) isostearyl ether are position isomers, differing only in the physical position of the -CH3 radical on either carbon 17 or carbon 16 of the alkyl chain. As such, one of ordinary skill in the art would reasonably expect polyoxyethylene (10) stearyl ether and polyoxyethylene (10) isostearyl ether to posess similar properties in the powder of Lee et al., Kubota et al., and Park et al. Based on all of the foregoing, claim 1 is rejected as prima facie obvious. Claim 7 is drawn to a cosmetic comprising the hydrophilized inorganic powder according to claim 1. Lee et al. further teach sun creams comprising the hydrophilized inorganic powder (Examples 6-8 on pg. 4). As such, claim 7 is rejected as prima facie obvious. Claim 19 further limits the process of making the hydrophilized inorganic powder of claim 1 and is therefore a product-by-process claim. As discussed in MPEP 2113(I), "[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process." In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). As the hydrophilized powder of claim 1 is obvious over Lee et al. in view of Kubota et al. and Park et al., claim 19 is also rejected as prima facie obvious for the same reasons applied to claim 1 above. Response to Arguments Applicant's arguments filed 22 April 2026 have been fully considered but are moot in view of the new grounds of rejection set forth above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Paul Hoerner whose telephone number is (571)270-0259. The examiner can normally be reached Monday - Friday 9:00am - 5:00pm eastern. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bethany Barham can be reached at (571)272-6175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BETHANY P BARHAM/Supervisory Patent Examiner, Art Unit 1611 /PAUL HOERNER/Examiner, Art Unit 1611
Read full office action

Prosecution Timeline

Jan 24, 2022
Application Filed
Jul 01, 2025
Non-Final Rejection mailed — §103, §112
Sep 29, 2025
Response Filed
Feb 24, 2026
Final Rejection mailed — §103, §112
Apr 22, 2026
Response after Non-Final Action
May 21, 2026
Request for Continued Examination
May 26, 2026
Response after Non-Final Action
Sep 23, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734135
CURCUMINOID COMPOSITIONS
5y 7m to grant Granted Sep 15, 2026
Patent 12735422
IMIDAZO-PYRIMIDONE COMPOUNDS AS PESTICIDES
3y 11m to grant Granted Sep 15, 2026
Patent 12702713
SEMI-SOLID, OIL-BASED PHARMACEUTICAL COMPOSITIONS CONTAINING PIRFENIDONE FOR APPLICATION IN TISSUE REPAIR
4y 11m to grant Granted Aug 11, 2026
Patent 12691064
INHALABLE THERAPEUTIC AGENT
4y 11m to grant Granted Jul 28, 2026
Patent 12691175
DRUG TRANSDERMAL DELIVERY SYSTEM
4y 6m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+62.1%)
3y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 82 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month